View by Specialty

Trending

Anthony A. Romeo
November 15, 2024
4 min read
Save

Capitalism is the path to value-based care

Neurosciences News

SPONSORED CONTENT
Save
SPONSORED CONTENT
January 16, 2006
1 min read
Save

Two classes of molecules in uveal melanoma suggest different treatments

NEW YORK — The identification of two distinct forms of molecules in uveal melanoma may lead to significant advances in the treatment of the disease, said one researcher speaking here.

SPONSORED CONTENT
January 09, 2006
1 min read
Save

Etanercept suppressed signs of Graves’ ophthalmopathy in trial

Etanercept, a drug used in the treatment of rheumatoid arthritis, may be beneficial in the treatment of Graves’ ophthalmopathy, a study suggests.

Trending

Anthony A. Romeo
November 15, 2024
4 min read
Save

Capitalism is the path to value-based care

SPONSORED CONTENT
December 29, 2005
1 min read
Save

Retinal pigment epithelial alterations leading factor in tumor growth

Patients with ocular tumors tend to have poor visual acuity, and patients with decalcified subfoveal choroidal osteoma have a particularly poor visual prognosis, according to results of a long-term study.

SPONSORED CONTENT
December 28, 2005
1 min read
Save

Etanercept, isoniazid may lead to optic neuritis

Two common drugs for the treatment of rheumatoid arthritis and tuberculosis may cause patients to develop optic neuritis, according to a case study. Discontinuation of the pharmaceuticals should help resolve the neuritis, the study authors said.

SPONSORED CONTENT
December 16, 2005
1 min read
Save

RPE cell implants show promise as Parkinson’s disease therapy

Implanting retinal pigment epithelial cells into the brain may be a beneficial treatment for Parkinson’s disease, a pilot trial in humans suggests.

SPONSORED CONTENT
December 09, 2005
1 min read
Save

Proton therapy planning device for ocular cancer given 501(k) clearance

PALO ALTO, Calif. — A calculation module for planning radiation treatments for eye cancers has been granted Food and Drug Administration 510(k) clearance, according to the device’s maker. The new proton therapy eye dose calculation module will be part of the Varian Eclipse treatment planning system, Varian said in a press release.

SPONSORED CONTENT
October 24, 2005
1 min read
Save

Treatment options promising for optic nerve sheath meningioma

CHICAGO — While there is still no ideal treatment for optic nerve sheath meningioma, recent advances in radiation therapy have provided promising outcomes that bode well for management of these tumors in the future, according to Neil R. Miller, MD.

SPONSORED CONTENT
October 19, 2005
1 min read
Save

Look for commonly missed etiologies to explain visual loss with normal fundus

CHICAGO — When confronted with unexplained visual loss in patients with a normal fundus, neuro-ophthalmologists should first seek to identify the anatomic location of the pathology and then, if no pathology is found, seek to prove that the visual loss is nonorganic, according to a presenter here.

SPONSORED CONTENT
October 17, 2005
1 min read
Save

Vision loss in cancer patients deserves special consideration

CHICAGO — General ophthalmologists and neuro-ophthalmologists alike must be aware that a history of cancer is an important factor in diagnosing vision loss in their patients, said Nicholas J. Volpe, MD. In patients with such a history, complications of cancer must be considered in the differential diagnosis to ensure proper management, he said.

SPONSORED CONTENT
October 12, 2005
1 min read
Save

Retinopathy a predictor of stroke in nondiabetics, Australian study finds

Retinopathy signs predict stroke or stroke-related death independent of traditional risk factors for stroke, an Australian population-based study found.

View more